Prokidney (PROK) Shares Outstanding (Diluted) (2021 - 2026)
Powered by 
Analysis
Prokidney (PROK) Shares Outstanding (Diluted) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn | 30.66 Mn |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - | 96.51 Mn |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn | 450.19 Mn |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn | 184.32 Mn |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn | 66.24 Mn |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - | 104.33 Mn |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn | 413.69 Mn |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn | 105.43 Mn |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn | 52.31 Mn |
| 10 | Prokidney | 346.07 Mn | 346.07 Mn | - | 186.56 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 186.56 Mn |
| Mar 31, 2026 | 141.93 Mn |
| Dec 31, 2025 | 133.94 Mn |
| Sep 30, 2025 | 134.99 Mn |
| Jun 30, 2025 | 130.73 Mn |
| Mar 31, 2025 | 128.98 Mn |
| Dec 31, 2024 | 97.92 Mn |
| Sep 30, 2024 | 126.17 Mn |
| Jun 30, 2024 | 75.91 Mn |
| Mar 31, 2024 | 60.95 Mn |
| Dec 31, 2023 | 61.71 Mn |
| Sep 30, 2023 | 61.59 Mn |
| Jun 30, 2023 | 64.56 Mn |
| Mar 31, 2023 | 61.54 Mn |
| Dec 31, 2022 | 61.54 Mn |
| Sep 30, 2022 | 61.54 Mn |
| Jun 30, 2022 | 31.89 Mn |
| Mar 31, 2022 | 5.50 Mn |
| Dec 31, 2021 | 5.50 Mn |
| Sep 30, 2021 | 5.50 Mn |